EVANSTON, Ill. --- Glaucoma, a leading cause of irreversible blindness, is associated with elevated pressure in the eye. This elevated pressure essentially is due to a plumbing problem. Fluid builds up in the eye, increasing pressure and eventually damaging the optic nerve. For nearly 150 years, researchers have been trying to understand what causes the blockage that prevents the eye from draining properly.
In a unique study of human ocular cells, a multi-institution research team led by a biomedical engineer at Northwestern University has found a new culprit. Glaucoma appears to be a consequence of mechanical dysfunction of endothelial cells -- a thin layer of cells that is the final barrier to fluid entering Schlemm’s canal, from which fluid then drains from the eye.
The researchers found that these endothelial cells from eyes with glaucoma are stiffer than cells from healthy eyes. This stiffness limits the cells’ ability to deform and allow a fluid called aqueous humor to cross the endothelium and drain into Schlemm’s canal. This increased flow resistance is responsible for the elevated pressure associated with glaucoma.
“There is no cure for glaucoma, which affects more than two million Americans,” said Mark Johnson, the senior author of the study. “Our work shows that cells of this endothelial layer act as mechanical gates. Therapeutic strategies that alter the stiffness of these cells potentially could lead to a cure for this debilitating disease.”
Johnson is a professor of biomedical engineering and mechanical engineering at Northwestern’s McCormick School of Engineering and Applied Science and a professor of ophthalmology at Northwestern University Feinberg School of Medicine.
Both Schlemm’s canal and the clear aqueous humor it drains from the eyeball are vital to the eye’s health and function. The aqueous humor nourishes the eye and maintains its proper pressure. Aqueous humor from the eye’s anterior chamber (located between the iris and cornea) collects in the canal from which it then flows into the vascular system. If the endothelial cells lining Schlemm’s canal are too stiff, it is difficult for them to form pores that allow the aqueous humor to pass through this thin layer and drain into the canal. Pressure then increases in the eye and eventually causes damage to the optic nerve at the back of the eye.
“The work appears to be one of the first times that the methods of mechanobiology -- the study of the mechanical characteristics of cells -- have been used to show that dysfunctional cell mechanics lies at the heart of a disease process,” Johnson said.
The title of the paper is “Altered mechanobiology of Schlemm’s canal endothelial cells in glaucoma.” Johnson’s co-authors on the study are from Imperial College London, the Harvard School of Public Health, Duke University, the Universität Regensburg in Germany, Georgia Institute of Technology and Emory University.
The work was supported by the National Institutes of Health (grants R01 EY 01969, R21 EY018373 and T32 EY007128), the National Glaucoma Research program of the Bright Focus Foundation, the Whitaker International Scholars Program, the Deutsche Forschungsgemeinschaft (FOR 1075, TP3), the Georgia Research Alliance and the Royal Society Wolfson Research Excellence Award.